SEC Form 4 · accession 0001140361-15-023273
INTERPACE BIOSCIENCES, INC. · IDXG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Gerald P. Belle
Director
Period of report
Jun 3, 2015
Accepted (ET)
Jun 4, 2015 · 6:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001054102
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 3, 2015 | A | 45,455 | $1.32 | A | 143,086 | D | |
| Common Stock | holding | — | — | — | 57,300 | I | By IRA | |
| Common StockF1 | holding | — | — | — | 97,631 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 2,479 restricted stock units("RSUs") that vest on June 5, 2015, 8,900 RSUs that vest on June 4, 2016, and 4,425 RSUs that vest on June 4, 2017.
- F2On June 3, 2015, the date of the Company's annual meeting of stockholders, Mr. Belle was granted 45,455 restricted stock units, of which 15,151 vest on June 3, 2016 and 15,152 vest on each of June 3, 2017 and June 3, 2018.